● pepmg Research Desk · Peer-reviewed evidence review
What the research says about Matrixyl (palmitoyl pentapeptide)
A neutral summary of the peer-reviewed literature on Matrixyl, a palmitoyl-pentapeptide cosmetic ingredient studied in fibroblast collagen assays and small topical trials. Research use only.
Limited evidence — Early or small human data, or strong preclinical work. This describes the state of the published literature, not a claim that this compound works, is safe, or is for human use. Research use only.
The short version
- Matrixyl is a cosmetic ingredient built on pal-KTTKS (palmitoyl pentapeptide-3/-4), a fragment of collagen (a matrikine) attached to a fatty acid to help it cross the skin [2].
- In laboratory studies it stimulates collagen production by human skin fibroblasts, and small topical trials of multi-ingredient formulas containing Matrixyl-family peptides reported improvements in skin roughness and tone [3][4].
- Because the human trials combine Matrixyl peptides with other actives, the peptide's individual contribution is hard to isolate, so the evidence is best described as limited [4][5].
- This page reports what the studies measured. It is not medical advice, an efficacy or safety claim, or dosing guidance. Research use only.
What Matrixyl is
Matrixyl is described in the literature as pal-KTTKS, a palmitoylated form of the pentapeptide KTTKS, which is itself a matrikine fragment released from the breakdown of type I collagen [2]. The trade names palmitoyl pentapeptide-3 and palmitoyl pentapeptide-4 refer to this and closely related peptides; the palmitoyl (fatty-acid) group is added to improve skin penetration of the otherwise water-soluble peptide [2][6].
It is sold as a cosmetic and research-chemical ingredient. This page summarizes the published research; material from third-party vendors is offered for laboratory and research use only.
What the human research has measured
Limited evidenceThe most direct evidence is in the laboratory. A study of the peptide amphiphile C16-KTTKS (marketed as Matrixyl) found that it stimulated collagen production by human dermal and corneal fibroblasts in a concentration-dependent manner, linking self-assembly of the peptide to its collagen-stimulating activity [3]. A separate study characterizing KTTKS analogs reported that these matrikine peptides stimulate extracellular-matrix production and types I and III collagen expression in vitro [2].
Human testing has largely used multi-ingredient formulas. An open-label trial of an anti-aging moisturizer containing a peptide blend (including palmitoyl tripeptide-38) alongside plant extracts, vitamin C, and coenzyme Q10 reported statistically significant improvement across all clinical grading parameters over 12 weeks in 37 subjects [4]. A study of a serum combining vitamins C and E with 5 ppm palmitoyl tripeptide-38 reported that skin-roughness parameters decreased significantly by about 8% to 9% over 56 days, with a 9% decrease in redness and an 8% increase in skin-tone homogeneity [5].
A double-blind randomized trial in 21 subjects compared acetyl hexapeptide-3 cream with palmitoyl pentapeptide-4 cream and placebo for crow's-feet wrinkles, reporting that the palmitoyl pentapeptide-4 group showed better results than the other two, while the authors described it as an initial study needing larger follow-up [7]. Because these formulas combine the peptide with other actives, isolating Matrixyl's own contribution is difficult.
What the studies report on safety and adverse events
Limited evidenceThe cosmetic studies reported good tolerability. The multi-ingredient moisturizer trial judged the product mild and well tolerated, with no statistically significant increase in any tolerability parameter versus baseline [4], and the KTTKS-analog laboratory study found that the synthesized pentapeptides were not cytotoxic to fibroblasts [2].
A 2026 methodology paper proposing a bioinformatic safety-evaluation framework for cosmetic peptides reported that palmitoyl pentapeptide-4 showed sequence homology with skin extracellular-matrix proteins (collagen, elastin, fibronectin) and did not raise the toxin or allergen flags that genuine toxins such as amanitin did in the same screen [6].
These are findings from cosmetic-use studies and screening tools, not a safety guarantee and not a prediction for any individual. This is not medical advice; consult a qualified professional and read the studies directly.
How strong is the evidence
The evidence is characterized as limited: the strongest data are in-vitro collagen-stimulation studies, and the human evidence comes from small trials of multi-ingredient formulas in which Matrixyl's individual effect cannot be cleanly separated [3][4][5]. "Limited" describes the maturity and design of the research, not a verdict that Matrixyl works, and it applies to topical cosmetic use.
Nothing here is dosing, medical, or safety guidance. Read the studies themselves and consult a qualified professional. This page is a map to the evidence, not a recommendation.
Sources · 6
- The Effects of a Novel Series of KTTKS Analogues on Cytotoxicity and Proteolytic Activity.
- Collagen stimulating effect of peptide amphiphile C16-KTTKS on human fibroblasts.
- An Open Label Clinical Trial of a Multi-Ingredient Anti-Aging Moisturizer Designed to Improve the Appearance of Facial Skin.
- A serum containing vitamins C & E and a matrix-repair tripeptide reduces facial signs of aging as evidenced by Primos analysis and frequently repeated auto-perception.
- A framework for the safety evaluation of peptides in cosmetics.
- Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow's Feet.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow any citation to its source and read it yourself. Research use only.